Oct 18, 2022
Our episode today focuses on a disease that’s a significant problem in the US. 15% of US adults or 37 million people, are estimated to have this disease and as many as 9 in 10 adults with this disease do not know they have it. This disease is prevalent in the 65+ population. As of 2018 Medicare was spending $70B annually on the treatment of this disease which represents almost 24 % of spending for this age group. If you haven’t yet figured out which disease I am referring to, its Chronic Kidney Disease or CKD.
The 21st Century Cures Act brought renal diseases to the forefront and allowed Medicare Beneficiaries with ESRD to enroll in a Medicare Advantage plan. Previously, these beneficiaries were required to stay on Traditional Medicare which often resulted in suboptimal outcomes. In addition, CMS has launched several innovative payment models in an attempt to help providers focus more on prevention and curbing progression of renal disease. As a result, many health plans and renal providers are now focused on more effectively managing renal conditions and improving outcomes.
With us today is Michael Uchrin, CEO of Monogram Health, a Nashville based company that helps patients with renal disease live their best lives. The team at Monogram Health is focused on making treatments as accessible and convenient as possible to the member, by offering in-home services. Michael will help educate us on the changes that are afoot and how companies like Monogram Health are improving outcomes and lowering costs.
Show Notes: Book - -Relentless: From Good To Great To Unstoppable by Tim Grover. Nashville Healthcare Council Fellows Program: https://healthcarecouncilfellows.com/